Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Infection Control and Hospital Epidemiology|April 1, 1999
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidisD O Garrett, E Jochimsen, K Murfitt, et al.
Journal of Clinical Microbiology|September 15, 2004
Uses of Staphylococcus aureus GeneChips in genotyping and genetic composition analysisP M Dunman, W Mounts, F McAleese, et al.
Journal of Clinical Microbiology|May 23, 1998
Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptidesF C Tenover, M V Lancaster, B C Hill, et al.
Diagnostic Microbiology and Infectious Disease|February 11, 1992
Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistanceH C Neu, R J Duma, R N Jones, et al.
Journal of Clinical Microbiology|March 1, 1979
Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimensP S Riley, D G Hollis, G B Utter, et al.
Infection Control and Hospital Epidemiology|April 1, 1999
The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institutionJ I Tokars, S Satake, D Rimland, et al.
Kidney International|September 29, 2001
Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centersJ I Tokars, T Gehr, W R Jarvis, et al.
The New England Journal of Medicine|February 18, 1999
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working GroupT L Smith, M L Pearson, K R Wilcox, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1980
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibioticsR N Jones, C Thornsberry, A L Barry, et al.
Pageof 22